"The retina specialists and surgeons of Retina Consultants of Minnesota provide advanced care to patients throughout Minnesota. Visit our retina center in Edina, MN for treatment of macular degeneration (AMD), diabetic retinopathy, retinal tears & detachments, macular edema, macular hole, uveitis, and more. We provide retinal diagnostic testing such as fluorescein angiography. Our treatments include eye injections (Avastin, Eylea, Lucentis), vitrectomy, and scleral buckle. We also participate in many retina clinical trials through our retina research center. Our locations in the Minneapolis-St. Paul Twin City area are easily accessible for patients in Edina, Blaine, Plymouth, St. Cloud, Woodbury, Bloomington, Eagan, Duluth, and beyond."

During the past decade, Vitreoretinal Surgery conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 8 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vitreoretinal Surgery" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Kodiak Sciences Inc" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "SurModics, Inc." with 1 trials sponsored and "University of Pennsylvania" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vitreoretinal Surgery" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Vitreoretinal Surgery" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (4 trials), "Age Related Macular Degeneration" (1 trials), "Choroidal Neovascularization" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Vitreoretinal Surgery" in a lesser frequency.

Most popular intervention types in "Vitreoretinal Surgery" are "Drug" (15 trials), "Other" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Aflibercept" (5 trials), "KSI-301" (4 trials), "Lampalizumab" (4 trials) and "Faricimab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Vitreoretinal Surgery" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Vitreoretinal Surgery". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Vitreoretinal Surgery, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vitreoretinal Surgery, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".